Finance

Lists
8WK:FRA
Abera Bioscience AB
€0.65
-3.26%
(-0.022) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8WK...
Open
€0.63
High
€0.65
Low
€0.62
Avg. vol.
3.00
Volume
0.00
52-wk high
€0.84
52-wk low
€0.44
No. of employees
6
Open
€0.63
High
€0.65
Low
€0.62
Avg. vol.
3.00
Volume
0.00
52-wk high
€0.84
52-wk low
€0.44
No. of employees
6
About Abera Bioscience AB
CEOMaria Alriksson
Employees6
Founded2012
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.92M
-939.00K
3.55M
1.56M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.70M
7.85M
9.30M
7.11M
Operating expense
5.79M
7.96M
9.39M
7.19M
Total operating expenses
5.79M
7.96M
9.39M
7.19M
Operating income
-867.00K
-8.90M
-5.83M
-5.63M
Other non operating income
-2.00K
1.00K
-
1.00K
EBT including unusual items
-835.00K
-8.80M
-5.80M
-5.56M
EBT excluding unusual items
-835.00K
-8.80M
-5.80M
-5.56M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
42.00K
49.00K
25.00K
15.00K
Net income
-835.00K
-8.80M
-5.80M
-5.56M
Net profit margin
-16.97%
936.85%
-163.13%
-355.66%
Earnings per share
-
-
-
-
Interest and investment income
34.00K
69.00K
40.00K
67.00K
Interest expense
-
-
-2.00K
-
Net interest expenses
34.00K
69.00K
38.00K
67.00K
Depreciation and amortization charges
45.00K
62.00K
63.00K
63.00K
EBITDA
-822.00K
-8.84M
-5.77M
-5.56M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps